tiprankstipranks
Advertisement
Advertisement

GB:AZN Stock Latest News

AstraZeneca says CARES Phase 3 clinical program did not meet primary endpoint
The FlyAstraZeneca says CARES Phase 3 clinical program did not meet primary endpoint
2d ago
AZN
AstraZeneca Imfinzi combination approved in the U.S.
PremiumThe Fly
AstraZeneca Imfinzi combination approved in the U.S.
2d ago
AZN
AstraZeneca Wins First U.S. Immunotherapy Combo Approval in Early Bladder Cancer
PremiumCompany Announcements
AstraZeneca Wins First U.S. Immunotherapy Combo Approval in Early Bladder Cancer
2d ago
AZN
AstraZeneca’s durvalumab approved in U.S. for NMIBC patients
PremiumThe Fly
AstraZeneca’s durvalumab approved in U.S. for NMIBC patients
2d ago
AZN
AstraZeneca confirms FDA approves Imfinzi combo for bladder cancer
PremiumThe Fly
AstraZeneca confirms FDA approves Imfinzi combo for bladder cancer
3d ago
AZN
FDA approves durvalumab combo for high-risk non-muscle invasive bladder cancer
PremiumThe FlyFDA approves durvalumab combo for high-risk non-muscle invasive bladder cancer
3d ago
AZN
AstraZeneca Advances Camizestrant Combo Trial in Advanced Breast Cancer
Premium
Company Announcements
AstraZeneca Advances Camizestrant Combo Trial in Advanced Breast Cancer
3d ago
AZN
AstraZeneca Maps Real-World Hypertension Care in Brazil: What Investors Should Watch
Premium
Company Announcements
AstraZeneca Maps Real-World Hypertension Care in Brazil: What Investors Should Watch
4d ago
AZN
AstraZeneca’s Brazil Hyperkalaemia Study Builds Real‑World Data Edge for AZN Investors
PremiumCompany Announcements
AstraZeneca’s Brazil Hyperkalaemia Study Builds Real‑World Data Edge for AZN Investors
4d ago
AZN
AstraZeneca’s OPTIMISE-CKD Update: What Dapagliflozin Real-World Data Could Mean for AZN Investors
PremiumCompany Announcements
AstraZeneca’s OPTIMISE-CKD Update: What Dapagliflozin Real-World Data Could Mean for AZN Investors
4d ago
AZN
CDT Equity granted Canadian patent for AZD5904 in male infertility
PremiumThe Fly
CDT Equity granted Canadian patent for AZD5904 in male infertility
4d ago
AZN
CDT
AstraZeneca says FDA extends PDUFA date to review camizestrant data for NDA
PremiumThe Fly
AstraZeneca says FDA extends PDUFA date to review camizestrant data for NDA
4d ago
AZN
FDA Extends Decision Timeline on AstraZeneca’s Camizestrant Breast Cancer Filing
PremiumCompany AnnouncementsFDA Extends Decision Timeline on AstraZeneca’s Camizestrant Breast Cancer Filing
4d ago
AZN
AstraZeneca: Buy Rating Reiterated on Undervalued Growth Outlook and Late-Stage Pipeline Upside; 16,500 GBp Price Target Maintained
Premium
Ratings
AstraZeneca: Buy Rating Reiterated on Undervalued Growth Outlook and Late-Stage Pipeline Upside; 16,500 GBp Price Target Maintained
5d ago
AZN
AstraZeneca Wins Landmark U.S. Approval for Datroway in Hard-to-Treat Breast Cancer
Premium
Company Announcements
AstraZeneca Wins Landmark U.S. Approval for Datroway in Hard-to-Treat Breast Cancer
5d ago
AZN
AstraZeneca’s Enhertu Wins Key EU Backing as First Tumour-Agnostic HER2 Therapy
PremiumCompany Announcements
AstraZeneca’s Enhertu Wins Key EU Backing as First Tumour-Agnostic HER2 Therapy
5d ago
AZN
AstraZeneca Wins EU Backing for Camizestrant Combo in First-Line Advanced ER-Positive Breast Cancer
PremiumCompany Announcements
AstraZeneca Wins EU Backing for Camizestrant Combo in First-Line Advanced ER-Positive Breast Cancer
5d ago
AZN
Citizens biotech analysts hold a dinnermeeting at ASCO
PremiumThe Fly
Citizens biotech analysts hold a dinnermeeting at ASCO
9d ago
AZN
LLY
AstraZeneca Extends COPD Bet With New Long‑Term Tozorakimab Safety Study
PremiumCompany Announcements
AstraZeneca Extends COPD Bet With New Long‑Term Tozorakimab Safety Study
9d ago
AZN
AstraZeneca Advances First-in-Human AZD8359 Study in Metastatic Prostate Cancer
PremiumCompany AnnouncementsAstraZeneca Advances First-in-Human AZD8359 Study in Metastatic Prostate Cancer
9d ago
AZN
Daiichi Sankyo, AstraZeneca’s Datroway approved in U.S to treat TNBC
Premium
The Fly
Daiichi Sankyo, AstraZeneca’s Datroway approved in U.S to treat TNBC
9d ago
AZN
AstraZeneca and Daiichi Sankyo’s Enhertu recommended in EU by CHMP in HER2
Premium
The Fly
AstraZeneca and Daiichi Sankyo’s Enhertu recommended in EU by CHMP in HER2
9d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >